Results 21 to 30 of about 1,353,059 (301)
Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood [PDF]
, 2005 BACKGROUND: Pulmonary arterial hypertension (PAH) is a potentially fatal vasculopathy that can develop at any age. Adult-onset disease has previously been associated with mutations in BMPR2 and ALK-1.Haworth, SG, Berger, R; id_orcid, Aldred, M A, Morrell, NW, Harrison, RE, Morrell, Nicholas W., Morrell, N W, Mache, CJ, Haworth, S G, Trembath, R C, Mache, Christoph J., Aldred, MA, Trembath, RC, Berger, Rolf, Aldred, Micheala A., Berger, R, Tulloh, R, Harrison, R E, Harrison, Rachel E., Haworth, Sheila G., Mache, C J, Trembath, Richard C., Tulloh, Robert +22 morecore +1 more sourceRight heart size and function significantly correlate in patients with pulmonary arterial hypertension – a cross-sectional study
Respiratory Research, 2018 Background The objective of this study was to assess, whether right atrial (RA) and ventricular (RV) size is related to RV pump function at rest and during exercise in patients with pulmonary arterial hypertension (PAH).Lukas Fischer, Nicola Benjamin, Norbert Blank, Benjamin Egenlauf, Christine Fischer, Satenik Harutyunova, Maria Koegler, Hanns-Martin Lorenz, Alberto M. Marra, Christian Nagel, Panagiota Xanthouli, Eduardo Bossone, Ekkehard Grünig +12 moredoaj +1 more sourceExploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension
BMC Pulmonary Medicine, 2017 Background Chronic inflammation emerges as a feature of the pathogenesis of pulmonary arterial hypertension (PAH) in experimental models. Alterations of circulating cell subsets have been observed in patients with PAH.Lars Harbaum, Kaaja M. Baaske, Marcel Simon, Tim Oqueka, Christoph Sinning, Antonia Glatzel, Nicole Lüneburg, Karsten Sydow, Carsten Bokemeyer, Hans Klose +9 moredoaj +1 more sourceNon-Invasive Pulmonary Artery Wave Intensity Analysis in Pulmonary Hypertension. [PDF]
, 2015 Pulmonary wave reflections are a potential hemodynamic biomarker for pulmonary hypertension (PH) and can be analyzed using wave intensity analysis (WIA). In this study we used pulmonary vessel area and flow obtained using cardiac magnetic resonance (CMR) Moledina, S, Coghlan, JG, Quail, MA, Knight, DS, Quail, Michael A, Muthurangu, Vivek, Taylor, Andrew M, Steeden, Jennifer A, Taelman, Liesbeth, Moledina, Shahin, Segers, P, Knight, Daniel S, Taylor, AM, Steeden, JA, Taelman, L, Segers, Patrick, Coghlan, J Gerry, Muthurangu, V +17 morecore +1 more sourceNeurohormonal modulation in pulmonary arterial hypertension
, 2021 Pulmonary hypertension is a fatal condition of elevated pulmonary pressures, complicated by right heart failure. Pulmonary hypertension appears in various forms; one of those is pulmonary arterial hypertension (PAH) and is particularly characterized by ...de Man, Frances S., Bogaard, Harm Jan, Noordegraaf, Anton Vonk, Peters, Eva L. +3 morecore +1 more sourceDistinct Platelet Ribonucleic Acid Signatures in Patients with Pulmonary Hypertension
, 2022 Rationale: Pulmonary hypertension encompasses progressive disorders leading to right ventricular dysfunction and early death. Late detection is an important cause of poor clinical outcomes.Smits, A Josien, Bogaard, Harm Jan, Arkani, Mohammad, In 't Veld, Sjors G J G, Jansen, Samara Ma, Botros, Liza, Boonstra, Anco, Best, Myron G, Braams, Natalia J, Zwaan, Kenn, de Man, Frances S, Sol, Nik, Post, Edward, Ramaker, Jip, Wurdinger, Tom, Vonk Noordegraaf, Anton, Huis In 't Veld, Anna E, Groeneveldt, Joanne A, Nossent, Esther J, Gomez-Arroyo, Jose +19 morecore +1 more sourceImpact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases
ERJ Open Research, 2023 Research questions
Patients with severe pulmonary hypertension associated with chronic lung disease have a poor prognosis. Targeted pulmonary arterial hypertension therapies might improve exercise capacity and outcome, but there are no guidelines on ...Romain Naud, Julien Bermudez, Noémie Resseguier, Ana Nieves, Bérengère Coltey, Nadine Dufeu, Clarisse Gautier, Youssef Trigui, Marc Laine, Benjamin Coiffard, Martine Reynaud-Gaubert +10 moredoaj +1 more sourceEXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI) [PDF]
, 2019 Pulmonary hypertension is highly heterogeneous and despite treatment advances it remains a life shortening condition. There have been significant advances in imaging technologies, but despite evidence of their potential clinical utility practice remains Swift, Andrew J., van Beek, Edwin, Olschewski, H., Horst Olschewski, Kiely, D., Screaton, Nicholas J, Michal Schafer, Rahaghi, F., David G. Kiely, Rebecca Vandepool, Tawhai, M., Mazurek, Jeremy, Rahaghi, Farbod N., Vogel-Claussen, J., Swift, Andrew, Levin, David L., Tawhai, Merryn, Ivy, David D, Andrew J. Swift, Swift, A., Van Beek, Edwin Jr, Angela Lungu, Schiebler, Mark, Schiebler, M., Bwika, J., Jone, P.-N., Dunbar Ivy, Kawut, S.M., Peacock, Andrew J., Stephen J. Wort, Kiely, David, Levin, D., Wild, J., David L. Levin, Puri, G D, Wild, Jim M, Olschewski, Horst, Schafer, M., Vanderpool, R.R., Vonk-Noordegraaf, Anton, G.D. Puri, Wort, John, Peacock, A., Hassoun, Paul M, Hassoun, Paul, Hassoun, Paul M., Jone, Pei-Ni, Lungu, Angela, Vanderpool, Rebecca R, Moledina, S., Bwika, Jumaa, Schiebler, Mark L, Kiely, David G., Shahin Moledina, Farbod N. Rahaghi, Jim Lordan, Levin, David, Jens Vogel‐Claussen, Kawut, Steven M, Rahaghi, Farbod N, Wort, J., Ivy, D.D., Wild, Jim, Pei‐Ni Jone, Kawut, Steven M., Andrew J. Peacock, Puri, Goverdhan Dutt, Mazurek, J., Jumaa Bwika, Lordan, Jim, Zhao, Lan, Tawhi, Merryn, Dunbar, Ivy, Van Beek, E.J., Mazurek, Jeremy A, Screaton, Nicholas, Vonk-Noordegraaf, A., Rahaghi, Farbod, Steven M. Kawut, Zhao, L., Anton Vonk‐Noordegraaf, Wort, Stephen J., Vandepool, Rebecca, Ivy, Dunbar, Wort, S John, Lordan, J., Wild, Jim M., Moledina, Shahin, van Beek, Edwin J. R., Schafer, Michal, Kiely, David G, Paul M. Hassoun, Jim M. Wild, Swift, Andrew J, Puri, G. D., Vogel-Claussen, Jens, Jeremy A. Mazurek, Lungu, A., Puri, G.D., Screaton, N., Mazurek, Jeremy A., Nicholas Screaton, Merryn Tawhai, Hassoun, P., Mark Schiebler, Peacock, Andrew, Lan Zhao, Edwin J.R. van Beek +107 morecore +1 more sourcePulmonary Hypertension [PDF]
Pulmonary Medicine, 2012 Pulmonary hypertension (PH), defined as elevated pulmonary artery pressure, is common in the general population and associated with increased mortality. Accordingly, physicians commonly encounter patients with dyspnea, exercise intolerance, and/or right heart failure who have elevated pulmonary artery systolic pressure (PASP) on echocardiography ...Ilknur Basyigit, Gulfer Okumus, Serpil Erzurum, Kewal Asosingh, Despina Papakosta +4 moreopenaire +5 more sourcesTemporal Trends in Diagnostic Hemodynamics and Survival of Patients with Pulmonary Hypertension: A Single-Center Study
Life, 2023 Advances in the diagnosis and treatment of pulmonary hypertension (PH) have gradually improved the disease course. This retrospective cohort study aims to explore the diagnostic hemodynamic profile and survival of PH patients and their temporal changes ...Georgios E. Papadopoulos, Alexandra Arvanitaki, Eleftherios Markidis, Sophia Anastasia Mouratoglou, Ioannis T. Farmakis, Panagiotis Gourgiotis, Thomas Chrysochoidis Trantas, Christos Feloukidis, Antonios Kouparanis, Matthaios Didagelos, Vasilis Grosomanidis, Antonios Ziakas, George Giannakoulas +12 moredoaj +1 more source
